REAKTIV-ORANGE DYPR 1410

Endpoint summary

Key value for chemical safety assessment

Effects on fertility

Description of key information

Read across for toxicity to reproduction from a one generation study of a structural analogue supported by data from two teratogenicity studies with structural analogues led to the conclusion that the test substance is expected to have no adverse effects on the reproductive system.

Link to relevant study records

Reference

Reference 1

Endpoint:

one-generation reproductive toxicity

Type of information:

read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Justification for type of information:

REPORTING FORMAT FOR THE ANALOGUE APPROACH
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
see attachment section 13

2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
see attachment section 13

3. ANALOGUE APPROACH JUSTIFICATION
see attachment section 13

Reason / purpose for cross-reference:

read-across source

Clinical signs:

no effects observed

Description (incidence and severity):

All effects seen with the source substance were due to the fluoride impurity, which is not contained in the target substance

Mortality:

no mortality observed

Description (incidence):

All effects seen with the source substance were due to the fluoride impurity, which is not contained in the target substance

Body weight and weight changes:

no effects observed

Description (incidence and severity):

All effects seen with the source substance were due to the fluoride impurity, which is not contained in the target substance

Food consumption and compound intake (if feeding study):

no effects observed

Description (incidence and severity):

All effects seen with the source substance were due to the fluoride impurity, which is not contained in the target substance

Clinical biochemistry findings:

no effects observed

Organ weight findings including organ / body weight ratios:

no effects observed

Histopathological findings: non-neoplastic:

no effects observed

Description (incidence and severity):

All effects seen with the source substance were a secondary effects resulting from the fluoride impurity, which is not contained in the target substance

Reproductive function: oestrous cycle:

no effects observed

Reproductive function: sperm measures:

not examined

Reproductive performance:

no effects observed

Description (incidence and severity):

All effects seen with the source substance were a secondary effects resulting from the fluoride impurity, which is not contained in the target substance

Dose descriptor:

NOAEL

Remarks:

General health

Effect level:

>= 1 000 mg/kg bw/day (nominal)

Sex:

male/female

Basis for effect level:

other: the only effects seen in the source substance were secondary effects resulting from broken-off incisors (fluorosis) from 0.3% fluoride impurity

Dose descriptor:

NOAEL

Remarks:

Reproductive performance

Effect level:

>= 1 000 mg/kg bw/day (nominal)

Sex:

male/female

Basis for effect level:

other: All effects observed were due to broken-off incisors resulting in lower food consumption and a lower pregnancy index. This effect was due to fluorosis of the rats' teeth caused by the 0.3% fluoride impurity

Critical effects observed:

no

Clinical signs:

no effects observed

Mortality / viability:

no mortality observed

Body weight and weight changes:

no effects observed

Description (incidence and severity):

All effects seen with the source substance were a secondary effects resulting from the fluoride impurity, which is not contained in the target substance

Sexual maturation:

no effects observed

Organ weight findings including organ / body weight ratios:

not examined

Gross pathological findings:

no effects observed

Histopathological findings:

not examined

Dose descriptor:

NOAEL

Generation:

F1

Effect level:

1 000 mg/kg bw/day (nominal)

Sex:

male/female

Basis for effect level:

other: effects observed on body weight of high-dose pups were due to broken-off incisors in dams resulting in lower food consumption. This effect was due to fluorosis of the rats' teeth caused by the 0.3% fluoride impurity

Reproductive effects observed:

no

Conclusions:

Daily oral administration of Structural Analogue 01 to rats during the premating, mating, gestation and lactation period at dose levels of 62.5 or 250 mg/kg body weight did not affect food consumption, body weight development, male or female mating/reproductive performance, fertility, gestation length as well as development of their progenity.
Daily oral administrations of 1000 mg/kg body weight (high-dose group) were well tolerated in rats within the first 5 weeks of treatment, but thereafter, from week 6 onwards, caused mortality due to dental lesions with subsequent disability of food uptake and starvation (clinical picture of dental fluorosis). This finding was time-dependent, with a threshold dose of 250 mg/kg body weight for males, and could be related to the fluoride impurity (0.3%) of this batch tested. This effect is not relevant for risk-assessment, as no fluorine is contained in the target substance.
Although there was marked pigment storage of the test compound in several organs, there was no clear functional or histopathological correlate that could be related to compound-induced systemic toxicity and/or specific reproductive toxicity. Impairment of reproduction and fertility at high dose parental animals was primarily the result of severe dental problems.
In the presence of severe dental problems at 1000 mg/kg bw and threshold dose of 250 mg/kg bw for this finding, there was no evidence of selective reproductive toxicity in rats for the Structural Analogue 01, according to the classification criteria of Commission Directive 2001/59/EC.
Furthermore, the effects seen are not relevant for the target substance, as no fluorine is contained in this substance.

Executive summary:

The present study was conducted in order to determine the effects of the Structural Analogue 01 on reproduction when administered orally by gavage to male and female Sprague Dawley rats during pre-mating, mating, gestation and lactation.

Groups of 28 male and 28 (27 in the high-dose group) female Spraque Dawley rats received the Structural Analogue 01 orally once daily at dose levels of 0, 62.5, 250 or 1000 mg/kg body weight for a period of 10 weeks (males) and 4 weeks (females), prior to mating. Dosing of males was continued during the whole mating period until sacrifice (approx. week 11 - 13 of the study). Treatment of mated females was continued until day 21 after littering. The dosing volume was 5 mL/kg, corresponding to concentrations of 0, 12.5, 50 and 200 mg/mL. At start of the study, the animals were 5-9 weeks of age with mean body weights of 240 g for males, and 206 g for females.

Behavior and state of health were observed daily in all groups. Body weight development and food consumption were recorded throughout the study in females, and during pre-mating period in males. After the mating period the males were killed and necropsied. The dams were allowed to litter and rear their progeny to the stage of weaning. Growth, development and behavior of the progeny were assessed during lactation. The dams as well as surviving pups were killed on day 22-24 post partum. Animals scheduled for necropsy on weekend were killed the next weekday.

At the time of sacrifice or death during the study the animals of the P generation were examined for macroscopically visible abnormalities. The main organs were weighed and the organ to body weight ratios calculated. Special attention was paid to the organs of the reproductive system. Histopathology of listed organs was performed in case of macroscopic visible changes. Moreover, dental mineral analyses (fluoride, calcium and phosphorus) were performed externally. In addition, clinical chemistry investigations, in particular for serum electrolytes, were performed in 10 animals per sex and group as amended to the protocol.

Body weights, food consumption, clinical chemistry data, absolute and relative organ weights and litter parameters were analyzed with the aid of a statistical program to show differences compared to the controls.

 

RESULTS

High-dose group (1000 mg/kg body weight): Besides the secondary effects resulting from the high fluoride content on rats' teeth, there wer no adverse effects noted on general health or reproduction.  Mean gestation length, (ca. 23.0 days), was not affected. Relative numbers of live pups, the mean number of implatations and birth index, was not adversely affected when related to the number of females at term with live pups. Mean viability index, weaning index, survival rate at day 21 was not affected.

Anatomic pathology revealed scondary effects resulting from the high concentration of fluoride in the tested batch of the source substance. As in the target substance no fluorine is contained, that finding has no effect on risk assessment of the substance. In addition, bluish discolorations of the whole carcasse and in several inner organs were also detected at necropsy due to the staining properties of the source substance. Microscopy confirmed intratubular pigment storage in the kidneys as a result of excretion and re-absorption of the dye. Furthermore, mixed cellular infiltrations in the submucosal area of the stomach as a result of irritating effects of the test compound due to the high salt-load during dayily gavage of the test substance administration were seen. There were no selective changes in sexual organs that could be related to selective reproductive toxicity in these dose group animals, nor were there any correlates of target organ toxicity.

Mid-dose group (250 mg/kg body weight): There were no premature deaths. No compound related clinical findings were recorded for the females. Food consumption, body weight development, mating and reproductive performance, fertility, mean gestation length, rearing and development of their offspring remained unaffected by administration of the test compound. Clinical chemistry, as well as anatomic pathology (necropsy, organ weights, histopathology) in particular of the sexual organs were generally unobstrusive, apart from pigment storage (dark brownish/or bluish discolorations) in the kidneys.

Low-dose group (62.5 mg/kg body weight): There were no premature deaths. No compound-related clinical signs were recorded in the P-generation male and female animals. Food consumption, body weight development, mating and reproductive performance, fertility, mean gestation length, rearing and development of their offspring remained unaffected by administration of the test compound. Clinical Chemistry, as well as anatomic pathology (necropsy, organ weights, histopathology) in particular of the sexual organs were unobstrusive.

By read across to the Structural Analogue 01, Reactive Orange DYPR 1410 is also deemed to have no toxicity to reproduction effects associated with it.

Reference 2

Endpoint:

one-generation reproductive toxicity

Type of information:

experimental study

Adequacy of study:

weight of evidence

Study period:

23 Jul 2001 to 12 Dec 2001

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 415 [One-Generation Reproduction Toxicity Study (before 9 October 2017)]

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU Method B.34 (One-Generation Reproduction Toxicity Test)

Deviations:

no

GLP compliance:

yes

Limit test:

no

Justification for study design:

The purpose of this study was to investigate the effect of orally administered test substance, on the fertility of male and female rats and early development of their offspring when administered to the P generation males and females prior to mating through to weaning of their pups. This includes effects of the test substance on gonadal function, estrous cycle, mating behavior, conception, pregnancy, intrauterine development of the conceptuses, parturition, lactation, weaning, growth, behavior and development of the offspring. Additionally, effects of the test substance on general state of health of the dams and on morbidity and mortality of the progeny were assessed.

Species:

rat

Strain:

Sprague-Dawley

Details on species / strain selection:

The rat has proved to be a suitable species for toxicological testing with many different substances and is the species of choice according to the international guidelines.

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Gartenstrasse 27, 33178 Borchen, Germany
- Age at study initiation: approximately 6 weeks
- Housing: single
- Diet (ad libitum): sniff R/M-Z (V1324)
- Water (ad libitum): tap
- Acclimation period: at least five days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): 30 to 70
- Air changes (per hr): 16-20 air changes per hour
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 31 July 2001 To: 12 December 2001

Route of administration:

oral: gavage

Vehicle:

water

Details on exposure:

PREPARATION OF DOSING SOLUTIONS:
The test item was dissolved daily in deionized water in concentrations of 12.5 mg/mL, 50 mg/mL and 200 mg/mL.

VEHICLE: deionized water
- Concentration in vehicle: 12.5 mg/mL, 50 mg/mL and 200 mg/mL
- Amount of vehicle: 5 mL/kg body weight

Details on mating procedure:

- M/F ratio per cage: 1:1 (1:2-mating was performed in three high dose females because of mortality in males)
- Length of cohabitation: three weeks
- Proof of pregnancy: vaginal plug or sperm in vaginal smear referred to as day 0 of pregnancy
- After successful mating each pregnant female was individually caged

Analytical verification of doses or concentrations:

yes

Details on analytical verification of doses or concentrations:

HPLC

Duration of treatment / exposure:

Males : 10 weeks pre-mating, treatment continued during mating (ca. 3 weeks)
Females : 4 weeks pre-mating, treatment continued during mating (ca. 3 weeks) and during lactation until day 21 post partum

Frequency of treatment:

daily

Details on study schedule:

NA

Dose / conc.:

62.5 mg/kg bw/day (nominal)

Remarks:

Concentration: 12.5 mg/mL

Dose / conc.:

250 mg/kg bw/day (nominal)

Remarks:

Concentration: 50 mg/mL

Dose / conc.:

1 000 mg/kg bw/day (nominal)

Remarks:

Concentration: 200 mg/mL

No. of animals per sex per dose:

28

Control animals:

yes, concurrent vehicle

Details on study design:

- Dose selection rationale: The dose rationale was based on a subacute 28-day oral toxicity study with the test compound in rats, which did not show any adverse findings up to and including the limit dose of 1000 mg/kg body weight. Accordingly, dose levels of 0, 62.5, 250 and 1000 mg/kg body weight per day were selected for the present study.

Parental animals: Observations and examinations:

CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily

CLINICAL OBSERVATIONS: Yes

BODY WEIGHT: Yes
- Time schedule for examinations: once weekly in both sexes during the pre-mating period
in females on day 0, 7, 14 and 21 during gestation and on day 0, 4, 7, 14 and 21 of lactation period.

FOOD CONSUMPTION: Food consumption was recorded together with the body weights (except the mating period for both genders, and except on day 4 of lactation for the females).

OTHER:
- Clinical Chemistry: 10 male and 10 female animals per group at scheduled sacrifice
Alanine Aminotransferase (ALAT or GPT), Albumin, Albumin / Globulin ratio, Alkaline Phosphatase, Aspartate Aminotransferase (ASAT or GOT), Bilirubin direct, Bilirubin total, Calcium, Chloride (CI-), Cholesterol, Creatinine, Globulin, Glucose, Inorganic Phosphorous, Potassium (K+), Sodium (Na+), Total Protein, Triglycerides, Urea, Uric Acid, y-Glutamyltranspeptidase

Oestrous cyclicity (parental animals):

daily during mating period

Sperm parameters (parental animals):

Parameters examined in all P male parental generations: testis weight, epididymis weight, prostate weight, seminal vesicles weight
histopathology of testis, epididymis, prostate, seminal vesicles

Litter observations:

STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of 8 pups/litter (4/sex/litter as nearly as possible); excess pups were killed and discarded.

PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, viability, physical or behavioural abnormalities

GROSS EXAMINATION OF DEAD PUPS:
yes, for external and internal abnormalities; possible cause of death was determined for pups born or found dead.

Postmortem examinations (parental animals):

SACRIFICE
- Male animals: All surviving animals were killed in the third week of the mating period
- Maternal animals: All surviving animals were killed on day 22 (or until day 24, after weekends), after birth. Animals with necropsy date on weekend were killed the next weekday

GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations. All abnormal findings with special attention paid to the organs of the reproductive system were recorded

HISTOPATHOLOGY / ORGAN WEIGHTS
The following tissues or organs (or pieces of them) were preserved in Bouin's solution (testes) and formaldehyde solution and processed for histopathological investigations: Epididymides, Kidneys, Liver, Ovaries with oviducts, Pituitary, Prostate, Seminal vesicle, Testes, Uterus, Vagina, all other gross lesions.
Histopathological examinations were carried out of the control and high dose animals on these organs, as well as on on heart, spleen, lung, pancreas and gastro-intestinal tract from those animals with macroscopically visible changes, i.e., blueish colored pigmentation storage of the test compound.
The following organs were weighed: Epidymides, Kidneys, Liver, Ovaries, Pituitary, Prostate, Seminal vesicle, Testes, Uterus

OTHER: In order to investigate the cause of the dental findings in the late treatment period of the high dose animals, in total five affected incisors of the high dose males and five incisors of the control animals were analyzed for calcium and phosphorous content (two high dose and two control animals, data not presented, filed in the raw data). Secondly they were extended to fluoride, calcium and phosphorous content on the remaining 3 high dose incisors and control incisors.

Postmortem examinations (offspring):

SACRIFICE
- The F1 offspring not selected as parental animals were sacrificed at 4 days of age.
- Dead or moribund pups and pups killed at day 4 were examinated for defects.

- All surviving F1-animals were killed on day 22 (or until day 24, after weekends), after birth. Animals with necropsy date on weekend were killed the next weekday

Statistics:

All Parameters: The assumption of a monotonic dose-response relationship for all parameters justifies the restriction of the significance level to 5 percent (per parameter and sex), using the method of: HOTHORN L, LEHMACHER W.: A Simple Testing Procedure "Control versus k Treatments" for One-sided Ordered Alternatives, with Application in Toxicology, Biom. J. 33, 179-189, Akademie Verlag
Bodyweights: The changes of parameter values compared to the treatment-free baseline values are analyzed with the t-Test:
HARTUNG J., ELPERT B., KLÖSENER K. H., Lehr- und Handbuch der angewandten
Statistik (1989), R. Oldenbourg Verlag, München
Clinical Pathology Data: Wilcoxon's Test: HOLLANDER M., WOLFE, D. A:, Nonparametric statistical methods
Organ weights (absolute): t-Test
Organ weights (relative to bodyweight): Wilcoxon's Test

Reproductive indices:

Copulatory index (%): Number of sperm positive females x 100 / Number of mated females
Fertility index - Males (%): Number of fertile males x 100 / Number of mated males
Fertility index - Females (%): Number of pregnant females x 100 / Number of mated females
Gestation index (%): Number of females with viable pups x 100 / Number of pregnant females
Sex ratio: (Number of pups examined - Number of males (females)) x 100 / Number of pups examined

Offspring viability indices:

Intra uterine mortality: (Number of implantations - Number of newborns) x 100 / Number of implantations
Total mortality: (Number of implantations - Number of viable pups) x 100 / Number of newborns
Viability index (%): Number of viable pups on day 4 (7, 14, 21) x 100 / Number of viable pups on day 0 (4, 7, 14)
Lactation index (%): Number of viable pups on day 21 x 100 / Number of viable pups on day 0 of lactation
Weaning index (%)

Clinical signs:

effects observed, treatment-related

Description (incidence and severity):

In the high dose group (1000 mg/kg), all males and females exhibited bluish-discoloured faeces, a few of them later on also bluish-discoloured urine. As a major clinical finding, the lower and/or upper incisors were white discoloured from week 5 onwards, and generally broke off within a few days. In particular some of those animals developed general clinical signs (stilted gait, hypoactivity, coat bristling, irregular respiration, respiratory sounds, diarrhoea, snout encrusted blood coloured or swollen etc.) and some of those ended up in a general poor condition. This was mainly due to the fact that they could not take up food properly as the high fluoride content contained as impurity in the test material affected the structure of the rats' teeth.
Blue discolored feces were observed in all P-generation male and female animals of the 250 mg/kg body weight group, males from day 22 and females from day 15 up to the end of the study. Two males exhibited broken-off upper incisors from weeks 12 or 7 onward. two other males had lower or upper incisors broken off from weeks 6 and 9 onwards, respectively. One male also showing stilted gait and squatting posture.
No substance-related clinical signs were observed in the P-generation male and female animals in the control and low dose group.

Mortality:

mortality observed, treatment-related

Description (incidence):

In the high dose group (1000 mg/kg body weight), 1 male and 1 female animal was found dead early (days 19 and 5, respectively) with unknown pathogenesis. In addition, further 6/28 males and 4/27 females were found dead or had to be killed on human grounds from study week 6-7 onwards, due to severely broken off- and white-discolored incisors, generally starting to occur from study week 6 onwards.
There were no intercurrent deaths in the control-, low- and mid-dose group animals.
The deaths of the high dose animals result from the high fluoride content contained as impurity in the test material affecting the teeth of the rats and is not due to toxicity of the substance itself

Body weight and weight changes:

effects observed, treatment-related

Description (incidence and severity):

Body weight gain was statistically significantly decreased for high dose males (10% within the first 6 weeks), with subsequent marked loss of body weight up to the end of treatment. In the high dose females, body weight gain was slightly increased during the first 4 weeks (pre-mating period), which, however, had turned back to a slight decrease during the gestation period (based on pregnant females only), and subsequent marked loss of body weight during lactation in surviving females. The marked loss of body weights in high dose animals was seen in those rats that had dental problems due to the high fluoride content contained as impurity in the test material affecting the structure of the rats' teeth..
Body weight gains were not significantly influenced by the administration of the test substance in the low- and mid-dose group (62.5 and 250 mg/kg).

Food consumption and compound intake (if feeding study):

effects observed, treatment-related

Description (incidence and severity):

Those high dose animals that were found dead from week 6 onwards or were killed on human grounds did not take up food a few days before death. Mean absolute food consumption in all remaining animals of the high dose group (1000 mg/kg) was slightly to moderately decrerased. This was in line with the lower body weight gains recorded for this group. Hence, relative food consumption was generally comparable in all groups throughout the study, except for high dose females, who exhibited a significant decrease of relative food consumption during the lactation period..
This decrease of food consumption resulted from defective teeth, as the high fluoride content contained as impurity in the test material affected the structure of the rats' teeth and is not a toxic effect of the test substance itself.

Clinical biochemistry findings:

effects observed, treatment-related

Description (incidence and severity):

At the end of the treatment period clinical chemistry was performed for 10 male and 10 female animals of each group in order to investigate possible influence of the test substance on the serum electrolyte and/or lipid/protein household, or on liver enzyme activity, as a possible cause of the dental clinical findings observed in particular for the high dose males and females.
However, these parameters were generally not affected by the test substance, in particular serum electrolytes were comparable in all treated groups to those of the controls.
There was a increase of mean total bilirubin in high dose males, which however, was an artefact as the disclouration of the serum by the test substance interferes with the photometrical measurement of bilirubin in the assay.
Other changes at 1000 mg/kg included slightly decreased triglycerides (females), and slightly decreased liver enzyme activity (ASAT, alkaline phosphatase), probably as a result of starvation in these animals resulting from a decrease of food consumption due to defective teeth, as the high fluoride content contained as impurity in the test material affected the structure of the rats' teeth.
No other changes of toxicological significance were recorded in any dose group animals.

Urinalysis findings:

effects observed, treatment-related

Description (incidence and severity):

In the high dose group (1000 mg/kg), some males and females exhibited bluish-discoloured bluish-discoloured urine as a result of the exrection of the test substance, which is a blue dye.

Behaviour (functional findings):

no effects observed

Organ weight findings including organ / body weight ratios:

effects observed, treatment-related

Histopathological findings: non-neoplastic:

effects observed, treatment-related

Description (incidence and severity):

There were no histopathological findings in the low-, and mid-dose groups which could be related to to the administration of the test substance. In the high-dose group, secondary effects due to starvation and resulting stress were noted and effects due to the excretion of the test substance like intratubular pigment in the kidneys. In addition, some animals showed a local inflammation in the submucosal area of the stomach, which is due to an irritating effect of the test material, containing a high salt concentration, which is deposited by gavage directly to the stomach mucosa.

Other effects:

effects observed, treatment-related

Description (incidence and severity):

Dental examinations: Analysis of the incisors from remaining 3 high dose males and three respective control males revealed burning concentrates of Fluor [µg/L] of 140 µg/L in high dose males cf./ 50 µg/L in the controls, indicating a significantly higher amount of Fluor in particular on the dental surface.
Physiologically, the fluoride content in rat teeth is very low. Rats are very sensitive to a higher fluoride intake, as the fluoride causes the rats' teeth to get brittle and brake, hindering food intake.
Broken incisors disabled animals concerned to take up food with the consequence of starvation and bad general health condition, a clinical picture of chronic dental fluorosis in rats, which is well described in public literature (Bucher, et al., 1991; Boulton et al., 1994; Angmar-Mansson, et al., 1984; etc.).

Reproductive function: oestrous cycle:

no effects observed

Reproductive function: sperm measures:

not examined

Reproductive performance:

effects observed, treatment-related

Description (incidence and severity):

All females of the control, low- and mid-dose group were recorded as being successfully mated (28/28 females per group) within mean pre coital intervals of 3.7, 5.0, 5.6 days, respectively, which is within the physiological range of variation for this rat strain. In the high dose group, only 23/27 females were detected sperm positive and recorded as being successfully mated.
At birth, the number of pregnancies were 22, 19, 22 and 12 for controls, low-, mid- and high dose females, respectively. There was one high dose female with dead pups at birth only. Hence, females at term with live pups counted 22, 19, 22, and 11 (controls, low- to high-dose groups). At 1000 mg/kg body weight, 3/11 females delivered normally developed pups, but had to be killed on human grounds up to day 4 post-partum as they were not able to rear their offspring, being in a status of starvation.
The mean number of implantations counted 13.6, 14.7, 14.9, and 13.5, with mean live pups/litter of 11.6, 11.1, 12.8 and 10.8; and a birth index of 88.1, 74.8, 86.2 and 83.5 % (control, low- to high dose, respectively) and hence, were comparable in all groups. In addition, supernumerary implantation sites, percentage of implantations, were not influenced by administration of the test substance.
Mean gestation length was comparable in all groups, i.e., 23.3, 23.5, 23.2 and 23.0, for controls, low- mid-, and high-dose groups, respectively.

CLINICAL SIGNS AND MORTALITY (PARENTAL ANIMALS)
There were no intercurrent deaths in the control-, low- and mid-dose group animals. In the high dose group (1000 mg/kg body weight), 1 male and 1 female animal was found dead early with unknown pathogenesis. In addition, further 6/28 males and 4/27 females were found dead or had to be killed on human grounds from study week 6-7 onwards. Animal No. 128 was killed by mistake on day 51.

Behavior and health status was not affected in low- and mid-dose group animals with the exception of 4 males exhibiting broken off incisors from week 6 onwards. Several high-dose animals had broken off- and white-discolored incisors, generally starting to occur from study week 6 onwards. Some of those animals developped general clinical signs (stilted gait, hypoactivity, coat bristling, irregular respiration, respiratory sounds diarrhea, snout encrusted blood colored or swollen etc.) and some of those ended up in a general poor condition.

Blue discolored feces were observed in all P-generation male and female animals of the 250 and 1000 mg/kg body weight groups.

BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
Body weight gain was significantly decreased for high dose animals that had dental problems.
Those high dose animals that were found dead from week 6 onwards or were killed on human grounds did not take up food a few days before death. Mean absolute food consumption in all remaining animals of the high dose group (1000 mg/kg) was slightly to moderately decrerased. This was in line with the lower body weight gains recorded for this group. Hence, relative food consumption was generally comparable in all groups throughout the study, except for high dose females, who exhibited a significant decrease of relative food consumption during the lactation period

REPRODUCTIVE FUNCTION: ESTROUS CYCLE (PARENTAL ANIMALS)
There were no test item related differences in the estrous cycle.

REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
Due to the lower food consumption resulting from broken-off incisors the pregnancy index was lower in high-dose females
The mean number of implantations counted, mean live pups/litter, birth index were comparable in all groups. In addition, supernumerary
implantation sites, percentage of implantations, were not influenced by administration of the test compound.
Mean gestation length was comparable in all groups.

ORGAN WEIGHTS
In high dose males, liver, kidney, testes, epididymides, prostate and seminal vesicles weight were slightly lower, with statistical significance, which was due to the reduction of terminal body weight and hence, not related to target organ toxicity.
The same applied for high dose females, where liver, kidney and uterus weight was slightly lower, with statistical significance.

GROSS PATHOLOGY (PARENTAL ANIMALS)
Males and females from the mid-dose group exhibited kidneys with dark brown discolorations. In addition, the kidneys of one male in this groups was bluish discolored.
The main relevant findings were discolorations in several organs animals of the high dose group. Further major alterations were white discolored or broken incisors in nearly all animals of this group.

HISTOPATHOLOGY (PARENTAL ANIMALS)
Histopathological findings in parental animals of the high-dose group at terminal killing revealed intratubular pigment in kidneys in 10 male and 5 female animals. Single animals exhibited degenerations or necrosis of tubular cells. Increased number of necrotic/apoptotic cells were found in the liver. Mixed cellular infiltrations in the submucosal area of the stomach were found particular in males.

Dose descriptor:

NOAEL

Remarks:

General health

Effect level:

62.5 mg/kg bw/day (nominal)

Sex:

male/female

Basis for effect level:

other: broken-off incisors (fluorosis) from 0.3% fluoride impurity

Dose descriptor:

NOAEL

Remarks:

Reproductive performance

Effect level:

1 000 mg/kg bw/day (nominal)

Sex:

male/female

Basis for effect level:

other: All effects observed were due to broken-off incisors resulting in lower food consumption and a lower pregnancy index. This effect was due to fluorosis of the rats' teeth caused by the 0.3% fluoride impurity

Critical effects observed:

no

Clinical signs:

no effects observed

Mortality / viability:

no mortality observed

Body weight and weight changes:

effects observed, treatment-related

Description (incidence and severity):

Clinical observation of live pups during lactation in the high-dose group (1000 mg/kg bw.) indicated that, in particular for those dams, being in a state of starvation, did not suckle their offspring sufficiently, which was visible by low amount of milk in the pups body.
Accordingly, the mean body weight of live pups during lactation was significantly decreased in the high dose offspring (1000 mg/kg bw.) from day 14, post partum onwards. Mean body weight was not affected in any other group.

Sexual maturation:

no effects observed

Organ weight findings including organ / body weight ratios:

not examined

Gross pathological findings:

no effects observed

Histopathological findings:

not examined

VIABILITY (OFFSPRING)
no effects

CLINICAL SIGNS (OFFSPRING)
no effects

BODY WEIGHT (OFFSPRING)
Mean body weight of live pups during lactation was significantly decreased in the high dose offspring (1000 mg/kg bw.) from day 14, post partum onwards. Mean body weight was not affected in any other group

Dose descriptor:

NOAEL

Generation:

F1

Effect level:

1 000 mg/kg bw/day (nominal)

Sex:

male/female

Basis for effect level:

other: effects observed on body weight of high-dose pups were due to broken-off incisors in dams resulting in lower food consumption. This effect was due to fluorosis of the rats' teeth caused by the 0.3% fluoride impurity

Critical effects observed:

no

Reproductive effects observed:

no

Conclusions:

Daily oral administration of the test substance to rats during the premating, mating, gestation and lactation period at dose levels of 62.5 or 250 mg/kg body weight did not affect food consumption, body weight development, male or female mating/reproductive performance, fertility, gestation length as well as development of their progenity.
Daily oral administrations of 1000 mg/kg body weight (high-dose group) were well tolerated in rats within the first 5 weeks of treatment, but thereafter, from week 6 onwards, caused mortality due to dental lesions with subsequent disability of food uptake and starvation (clinical picture of dental fluorosis). This finding was time-dependent, with a threshold dose of 250 mg/kg body weight for males, and could be related to the fluoride impurity (0.3%) of this batch tested.
Although there was marked pigment storage of the test compound in several organs, there was no clear functional or histopathological correlate that could be related to compound-induced systemic toxicity and/or specific reproductive toxicity. Impairment of reproduction and fertility at high dose parental animals was primarily the result of severe dental problems.
In the presence of severe dental problems at 1000 mg/kg bw and threshold dose of 250 mg/kg bw for this finding, there was no evidence of selective reproductive toxicity in rats.

Executive summary:

The present study was conducted in order to determine the effects of the test substance on reproduction when administered orally by gavage to male and female Sprague Dawley rats during pre-mating, mating, gestation and lactation.

Groups of 28 male and 28 (27 in the high-dose group) female Spraque Dawley rats received the test substance orally once daily at dose levels of 0, 62.5, 250 or 1000 mg/kg body weight for a period of 10 weeks (males) and 4 weeks (females), prior to mating. Dosing of males was continued during the whole mating period until sacrifice (approx. week 11 - 13 of the study). Treatment of mated females was continued until day 21 after littering. The dosing volume was 5 mL/kg, corresponding to concentrations of 0, 12.5, 50 and 200 mg/mL. At start of the study, the animals were 5-9 weeks of age with mean body weights of 240 g for males, and 206 g for females.

Behavior and state of health were observed daily in all groups. Body weight development and food consumption were recorded throughout the study in females, and during pre-mating period in males. After the mating period the males were killed and necropsied. The dams were allowed to litter and rear their progeny to the stage of weaning. Growth, development and behavior of the progeny were assessed during lactation. The dams as well as surviving pups were killed on day 22-24 post partum. Animals scheduled for necropsy on weekend were killed the next weekday.

At the time of sacrifice or death during the study the animals of the P generation were examined for macroscopically visible abnormalities. The main organs were weighed and the organ to body weight ratios calculated. Special attention was paid to the organs of the reproductive system. Histopathology of listed organs was performed in case of macroscopic visible changes. Moreover, dental mineral analyses (fluoride, calcium and phosphorus) were performed externally. In addition, clinical chemistry investigations, in particular for serum electrolytes, were performed in 10 animals per sex and group as amended to the protocol.

Body weights, food consumption, clinical chemistry data, absolute and relative organ weights and litter parameters were analyzed with the aid of a statistical program to show differences compared to the controls.

 

RESULTS

High-dose group (1000 mg/kg body weight): There were 7 males and five females that were found dead or killed on humane grounds due to starvation and bad general health condition as a cause of broken off incisors and subsequent disability of food uptake. In addition, one female was killed with dead pups at birth, another one with live pups was killed on lactation day 6 due to inability to suckle them properly. Teeth trimming were carried out to insure food uptake during mating procedures for as many animals concerned as possible. Mean food consumption and body weight development was decreased during pre-mating (males) and during the lactation period (surviving females). Mean gestation length, (ca. 23.0 days), was not affected. Because of these unscheduled deaths the number of pregnancies was markedly reduced (12 cf./22 of control). The absolute number of females at term with live pups was reduced (11 cf./21 of control), with lower absolute number of implantations. One dam had dead pups only. However, relative numbers of live pups, the mean number of implatations and birth index, was not adversely affected when related to the number of females at term with live pups. During early lactation, 4/11 females had to be killed on humane grounds, as they were not able to rear their healthy offspring due to starvation. The remaining 7 females reared their healthy offpring up to the end of the lactation period, however, mean pup body weight gains were significantly decreased from day 14 post partum up to the end of the study. Mean viability index, weaning index, survival rate at day 21 was not affected. There was one unreared litter recorded for this group. The pups did not show any macroscopically visible abnormalities.

Apart from significantly increased total bilirubin levels, clinical pathology was unobstrusive, also with regard to serum electrolytes. This increase is an artefact because the disclouration of the serum by the test substance interferes with the photometrical measurement of bilirubin in the assay. Anatomic pathology revealed severe dental lesions (broken off, deformed and white discolored incisors), which were confirmed to contain a 3-fold concentration of fluoride. Fluoride (0.3%) was identified as an impurity of the test compound batch, tested in this study. Massive bluish discolorations of the whole carcasse and in several inner organs were also detected at necropsy. Microscopy confirmed intratubular pigment storage in the kidneys, increased number of necrotic/apoptotic cells in the liver as a histopathological correlate of clinical starvation, and mixed cellular infiltrations in the submucosal area of the stomach, probably as a result of irritating effects of the test compound. There were no selective changes in sexual organs that could be related to selective reproductive toxicity in these dose group animals, nor were there any correlates of target organ toxicity.

Mid-dose group (250 mg/kg body weight): There were no premature deaths. No compound related clinical findings were recorded for the females. Four males had broken-off incisors during the late treatment period (weeks 6 -12). However, food consumption, body weight development, mating and reproductive performance, fertility, mean gestation length, rearing and development of their offspring remained unaffected by administration of the test compound. Clinical chemistry, as well as anatomic pathology (necropsy, organ weights, histopathology) in particular of the sexual organs were generally unobstrusive, apart from pigment storage (dark brownish/or bluish discolorations) in the kidneys.

Low-dose group (62.5 mg/kg body weight): There were no premature deaths. No compound-related clinical signs were recorded in the P-generation male and female animals. Food consumption, body weight development, mating and reproductive performance, fertility, mean gestation length, rearing and development of their offspring remained unaffected by administration of the test compound. Clinical Chemistry, as well as anatomic pathology (necropsy, organ weights, histopathology) in particular of the sexual organs were unobstrusive.

 

Effect on fertility: via oral route

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

NOAEL

1 000 mg/kg bw/day

Study duration:

subchronic

Species:

rat

Effect on fertility: via inhalation route

Endpoint conclusion:

no study available

Effect on fertility: via dermal route

Endpoint conclusion:

no study available

Additional information

A modified one-generation study was carried out with structural analogue 01. This test substance contained a higher content (0.3%) of fluoride as impurity in the test substance resulting in fragility of the incisors and a very low food uptake in high-dose dams. Consequently, the survival rate in the high-dose group was rather low. However, daily oral administration of the test substance to rats during the premating, mating, gestation and lactation period at dose levels of 62.5 or 250 mg/kg body weight/day, where the absolute fluoride uptake was distinctly lower, did not affect food consumption, body weight development, male or female mating/reproductive performance, fertility, gestation length as well as development of their progeny. Daily oral administrations of 1000 mg/kg body weight were well tolerated in rats within the first 5 weeks of treatment, but thereafter, from week 6 onwards, caused mortality due to dental lesions with subsequent disability of food uptake and starvation (clinical picture of dental fluorosis). Consequently, due to the fact that no fluoride is contained in Reactive Orange DYPR 1410, a NOAEL of 1000 mg/kg body weight is expected for the test substance for parental reproductive performance and their offspring.

Effects on developmental toxicity

Description of key information

No teratogenic or developmental effects were noted in developmental studies with structural analogues.

Link to relevant study records

Reference

Reference 1

Endpoint:

developmental toxicity

Type of information:

read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

supporting study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Justification for type of information:

REPORTING FORMAT FOR THE ANALOGUE APPROACH
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
see attachment section 13

2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
see attachment section 13

3. ANALOGUE APPROACH JUSTIFICATION
see attachment section 13

Reason / purpose for cross-reference:

read-across source

Clinical signs:

no effects observed

Description (incidence and severity):

The effects observed in the structural analogue were due to an elevated fluorid impurity and are hence not relevant for the test substance

Mortality:

no mortality observed

Body weight and weight changes:

no effects observed

Description (incidence and severity):

The effects observed in the structural analogue were due to an elevated fluorid impurity and are hence not relevant for the test substance

Food consumption and compound intake (if feeding study):

no effects observed

Description (incidence and severity):

The effects observed in the structural analogue were due to an elevated fluorid impurity and are hence not relevant for the test substance

Haematological findings:

no effects observed

Clinical biochemistry findings:

no effects observed

Behaviour (functional findings):

no effects observed

Organ weight findings including organ / body weight ratios:

no effects observed

Gross pathological findings:

no effects observed

Histopathological findings: non-neoplastic:

no effects observed

Number of abortions:

no effects observed

Description (incidence and severity):

The effects observed in the structural analogue were due to an elevated fluorid impurity and are hence not relevant for the test substance

Pre- and post-implantation loss:

no effects observed

Description (incidence and severity):

The effects observed in the structural analogue were due to an elevated fluorid impurity and are hence not relevant for the test substance

Total litter losses by resorption:

no effects observed

Description (incidence and severity):

The effects observed in the structural analogue were due to an elevated fluorid impurity and are hence not relevant for the test substance

Early or late resorptions:

no effects observed

Description (incidence and severity):

The effects observed in the structural analogue were due to an elevated fluorid impurity and are hence not relevant for the test substance

Dead fetuses:

no effects observed

Changes in pregnancy duration:

no effects observed

Changes in number of pregnant:

no effects observed

Dose descriptor:

NOAEL

Effect level:

>= 1 000 mg/kg bw/day

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Fetal body weight changes:

no effects observed

Reduction in number of live offspring:

no effects observed

Changes in sex ratio:

no effects observed

Changes in litter size and weights:

no effects observed

Changes in postnatal survival:

no effects observed

External malformations:

no effects observed

Skeletal malformations:

no effects observed

Visceral malformations:

no effects observed

Dose descriptor:

NOAEL

Effect level:

> 1 000 mg/kg bw/day

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Remarks:

The only effect seen in the source substance was a slightly higher post-implantation loss due to rat specific dental fluorosis in dams resulting from a higher amount of a fluoride impurity at the highest dose level

Abnormalities:

no effects observed

Developmental effects observed:

no

Conclusions:

Slightly lower body weight gains and a slight initial reduction in feed consumption resulting in slightly lower numbers of live foetuses at birth (not statistically significant) and a slightly higher post-implantation loss were observed at at 1000 mg/kg body weight/day with the source substance. These effects were due to dental problems, resulting from higher fluoride uptake leading to a higher brittleness of the rats' teeth. As Reactive Orange DYPR 1410 does not contain fluorine or fluoride as an impurity, these effects are of not relevance for the risk assessment of the test substance. Individual examination and statistical evaluation of external, visceral and skeletal effects did not reveal any substance related findings, including the high dose group. Hence the test substance was not teratogenic in the rat at either dose level..
Neither maternal nor embryo-foetal toxicity was observed after administration of at the daily dose of 250 mg/kg body weight. With regard to the present study the 'No Observed Effect Level' (NOEL) is 250 mg/kg bw/day for maternal toxicity and embryotoxicity and the NOAEL is considered to be 1000 mg/kg bw/day or above.

Executive summary:

The present study was conducted in order to determine the effects of the Structural Analogue 01 (SA01) on maternal state of health, embryonic and foetal development when administered oral by gavage once daily to mated female Sprague Dawley rats from day 6 - 19 of pregnancy.

Groups of 23 mated female Sprague Dawley rats received the test item as a solution in deionized water oral by gavage once daily at the dose levels of 62.5, 250 or 1000 mg/kg body weight from day 6 - 19 of pregnancy (day 0: day of sperm detection) and were sacrificed on day 20 of pregnancy. The dosing volume was 5 mL/kg, corresponding to concentrations of 0, 12.5, 50 and 200 g/L.

Animals were observed daily for mortality and clinical signs of toxicity. Body weight and food consumption were determined regularly throughout the study.

At necropsy the dams were examined for macroscopically visible changes. The uterus was opened and the number of live and dead foetuses and the number of conceptuses undergoing resorption were determined. Body weights, crown-rump lengths, sex ratios of the foetuses and placental weights were determined and external, visceral and skeletal examinations of the foetuses performed.

RESULTS

Neither deaths nor substance-related clinical signs of intoxication occurred throughout the study. The faeces of high dose dams was dark discoloured.

Body weights gains of all pregnant females were slightly decreased in the high dose group (1000 mg/kg bw/day) during the treatment period, attaining statistical significance (p<0.05) at the end of treatment only. Statistical evaluation showed an initial reduction (p<0.05) of feed consumption in this group (study days 3-6) with subsequent recovery thereafter. Effects on body weight and food consumption in the high dose groups were further investigated in the extended one-generation study and were unequivocally related to the dental problems due to the higher fluoride content of the test item. As Reactive Orange DYPR 1410 does not contain fluoride or fluorine, this effect is not relevant for risk assessment.

Body weight gains and food consumption remained unaffected by the administration of the test substance in the other groups.

 

No substance-related adverse effects were observed at necropsy. The kidneys of all high dose group females, and of a few mid dose group females, were dark discoloured, indicating systemic bioavailability and metabolic burden of the test substance in the body.

There was a slight increase in the number of early or late conceptuses undergoing resorption (post-implantation loss), as well as a slight and not statistically significant decrease in the number of live foetuses at birth in the high dose dams, resulting from the lower body weights and food consumption due to dental problems relating to the higher fluoride intake in this dose-group. No such findings were observed for mid or low dose group females. Foetal crown-rump lengths, litter size, sex ratios, foetal body weight and placental weights remained unaffected by the administration of the test substance in any group. External, visceral and skeletal examinations of the foetuses did not reveal any substance related alterations in any group.

 

CONCLUSION

In conclusion, slightly lower body weight gains and a slight initial reduction in feed consumption were observed in pregnant female Sprague Dawley rats after administration of the test item at the daily dose of 1000 mg/kg body weight/day during days 6-19 of gestation. This was related to dental problems, as the higher fluoride uptake (0.3% fluoride was identified as an impurity of the test substance) leads to a higherbrittleness of the teeth for rats. Hence this effect is not of importance for Reactive Orange DYPR 1410. Resulting from the lower feed intake, high dose dams had slightly lower numbers of live foetuses at birth (not statistically significant) and a slightly higher post-implantation loss when compared to the control. In the presence of a normal intrauterine development of the remaining conceptuses, these findings were still on the lower/upper range of biological variation for this rat strain and hence, considered to be of equivocal toxicological significance. Moreover, individual examination and statistical evaluation of external, visceral and skeletal effects did not reveal any substance related findings, including the high dose group.

Neither maternal nor embryo-foetal toxicity was observed after administration of at the daily dose of 250 mg/kg body weight. The test substance was not teratogenic in the rat. With regard to the present study the 'No Observed Effect Level' (NOEL) is 250 mg/kg bw/day for maternal toxicity and embryotoxicity and the NOAEL is considered to be 1000 mg/kg bw/day with regard to human risk assessment.

There was no evidence of developmental toxicity in rats for the test substance, according to the classification criteria of Commission Directive 2001/59/EC.

Reference 2

Endpoint:

developmental toxicity

Type of information:

experimental study

Adequacy of study:

supporting study

Study period:

2001/2002

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 414 (Prenatal Developmental Toxicity Study)

GLP compliance:

yes (incl. QA statement)

Limit test:

no

Species:

rat

Strain:

Sprague-Dawley

Details on test animals or test system and environmental conditions:

- Source: Harlan Winkelmann GmbH, Gartenstrasse 27, 33178 Borchen, Germany
- Age at study initiation: approximately 8 - 10 weeks
- Housing: single
- Diet (ad libitum): sniff R/M-Z (V1324)
- Water (ad libitum): tap
- Acclimation period: at least five days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): 30 to 70
- Air changes (per hr): 16-20 air changes per hour
- Photoperiod (hrs dark / hrs light): 12/12

Route of administration:

oral: gavage

Vehicle:

water

Remarks:

deionised

Details on exposure:

PREPARATION OF DOSING SOLUTIONS:

The test item was dissolved daily in deionized water in concentrations of 12.5 mg/mL, 50 mg/mL and 200 mg/mL.
Application volume : 5 mL/kg bw.

Analytical verification of doses or concentrations:

yes

Details on analytical verification of doses or concentrations:

First and last week of treatment

Details on mating procedure:

Virgin female animals in the pre-oestrus or oestrus phase were mated overnight with sexually mature males in the ratio 1 male : 1 female and were caged individually after the detection of sperm in vaginal smears. The day of sperm detection was defined as day 0 of gestation. Pregnancy was confirmed at necropsy by the detection of implantation sites or normally developed corpora lutea.

Duration of treatment / exposure:

day 6 to 19 of gestation

Frequency of treatment:

daily

Duration of test:

cesarean section on day 20 of gestation

No. of animals per sex per dose:

23

Control animals:

yes, concurrent vehicle

Details on study design:

- Dose selection rationale:
In a preliminary study groups of 6 mated female Sprague Dawley rats receivedthe test item orally by gavage once daily at the dose levels of 1000 mg/kg body weight/day from day 6 - 19 of pregnancy and were sacrificed on day 20 of pregnancy.
No compound-related clinical signs were observed. at the dose of 1000 mg/kg body weight. Body weight development and food consumption were considered not to be affected, based on the limited number of animals tested. No abnormalities were observed at necropsy of the animals. No abnormalities were detected at caesarean section. Embryofetal development was not impaired (Report No.: PT01-0026).
Based on the results of this study, the dose levels of 0 mg/kg bdwt, 62.5, 250, and 1000 mg/kg bw/day were selected for the present study.

Maternal examinations:

Body weight
Animals were weighed on days 0, 3, 6, 9, 13, 16, 18 and 20 of pregnancy.

Food consumption
Food consumption was determined on days 0-3, 3-6, 6-9, 9-13, 13-16, 16-18 and 18-20 of pregnancy.

Mortality and clinical observations
All animals were examined before the start of the study and were shown to be in good general health condition.
The behavior and general health condition of the animals were examined at least twice daily (on weekends and public holidays once daily).

CAESAREAN SECTION AND POST MORTEM EXAMINATIONS
The animals were killed on day 20 of pregnancy and the fetuses removed by Caesarean section.
All animals were examined externally and internally (thoracic and abdominal contents) for macroscopically visible changes, with emphasis on the uterus. Gravid uterus weight was recorded.

Ovaries and uterine content:

The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes

All animals were examined externally and internally (thoracic and abdominal contents) for macroscopically visible changes, with emphasis on the uterus. Gravid uterus weight was recorded.
The live and dead fetuses in the uterus as well as the conceptuses undergoing resorption and corpora lutea were counted, identified in numerical sequence from cervix to ovary and examined macroscopically. The implantation sites in the uterus were counted after staining with ammonium
sulphide.
The fetuses, the placentae and conceptuses undergoing resorption were removed from the uterus, weighed or measured and examined for gross external abnormalities.

Fetal examinations:

The live and dead fetuses in the uterus as well as the conceptuses undergoing resorption and corpora lutea were counted, identified in numerical sequence from cervix to ovary and examined macroscopically. The implantation sites in the uterus were counted after staining with ammonium
sulphide.
The fetuses, the placentae and conceptuses undergoing resorption were removed from the uterus, weighed or measured and examined for gross external abnormalities. Then the fetuses were killed by CO2 asphyxia.
Approximately 50% of the fetuses of each litter and the dead fetuses were fixed in alcohol, necropsied, sexed and checked for anomalies of the internal organs. The carcasses were placed in a solution of potassium hydroxide for clearing and stained with alizarin red S and Alcian blue. The skeletons were examined and checked for stage of development and abnormalities with the aid of a stereomicroscope.
The remaining fetuses were transferred in Bouin's solution, examined for organ anomalies referring to Wilson's slicing technique [Wilson, J.G.: Embryological considerations in teratology. In Teratology: Principles and Techniques (J.G. Wilson, J. Warkany, Ed.), page 251-277. University of Chicago Press, Chicago, IL (1965)] and sexed.
Visceral and skeletal changes were subdivided into four categories (major defects, minor defects, variations and retardations) based on the severity and/or the spontaneous incidence of the finding.

Statistics:

see below

Indices:

- Pre-implantation loss: Number of corpora lutea - Number of implantations x 100 / Number of corpora lutea
- Post-implantation loss: Number of implantations - Number of live fetuses - x 100 /Number of implantations

FETUSES
- Sex distribution: Number of Male (Female) fetuses x 100 / Number of fetuses
- External abnormalities/litter: Number of fetuses with abnormality x 100 / Number of fetuses
- Visceral abnormalities/litter: Number of fetuses with abnormality - x 100 / Number of fetuses
- Skeletal abnormalities/litter: Number of fetuses with abnormality x 100 / Number of fetuses

Historical control data:

yes

Details on maternal toxic effects:

Maternal toxic effects:yes

Details on maternal toxic effects:
Body weight development
Mean body weight of all pregnant high dose females (1000 mg/kg bw) was slightly decreased (ca. 5%) against the control, attaining statistical significance (p<0.05) only during late pregnancy (study day 20). Accordingly, overall body weight gain during treatment (study days 6 — 20) was slightly reduced in high dose females (96.9g cf./106.9g for controls). Mean body weight and body weight gains were not influenced by the administration of the test substance in mid and low dose groups.

Food consumption
A transient reduction in absolute food consumption was noted for high dose dams only during the initial treatment period between study days 6-9, with subsequent food uptake comparable to the controls, thereafter. As an incidental finding, relative food intake was slightly significantly reduced against the control during study days 3-6 (prior to treatment). Absolute / relative food consumption was not influenced by the administration of the test substance in mid and low dose groups.

Mortality and clinical observations
Neither deaths nor substance-related adverse clinical signs of intoxication occurred throughout the study. All high dose dams exhibited discolored feces.

Necropsy findings
No substance-related adverse findings were observed at necropsy in all dose groups. Bioavailability of the test substance was confirmed in the kidneys of all dose groups, which were black discolored (all high dose dams) or dark brown (22/23 mid dose dams, 2/23 low dose dams). In addition, the right kidney of one high dose female was enlarged, with a dilated pelvis a second animal of the high dose group showed a with fluid filled kidney. This finding is not unusual for this rat strain and hence, was considered not to be substance-related.

Gestation and caesarean section data
Pregnancy rates accounted 18/23, 20/23, 17/23 and 17/23 females from control, low, mid and high dose groups, respectively. All of these pregnant animals had live fetuses at term. There were no dams with either abortions, premature delivery, or females at term with intrauterine deaths only, at any group.
Early intrauterine deaths accounted 7, 16, 11, and 23 (control — high dose, respectively). Post-implantation loss [%] accounted 3.50, 5.65, 6.41, and 12.82 (control — high dose, respectively), and hence, increased with dose. All percentage figures were within the range of biological variation (<17%) for this rat strain and hence considered not to be biologically relevant. However, a substance-related influence cannot be excluded with certainty although the conceptuses undergoing resorption generally had diameters between 2 and 8 mm with no difference among the groups. There was one case of 16 mm in the control, and 2 cases of 10 mm in the high dose group.
Live fetuses accounted 203, 249, 203, and 169 for the control - high dose groups, respectively, with mean litter sizes of 11.3, 12.5, 11.9, and 9.9, respectively. The lower tendency of live fetuses/litter size for the high dose group against all other groups was not statistically significant, and within the physiological range for this rat strain and age. Hence, it was considered to be possibly incidental, not related to the administration of the test substance.

Dose descriptor:

NOAEL

Effect level:

1 000 mg/kg bw/day

Based on:

test mat.

Basis for effect level:

other: maternal toxicity

Details on embryotoxic / teratogenic effects:

Embryotoxic / teratogenic effects:no effects

Details on embryotoxic / teratogenic effects:
Findings at caesarean section
There were no findings at caesarian section in any group fetuses, which could be related to the test substance administration.

External, skeletal and visceral examination
Statistical Evaluation (Jackknife t-test, p<0.05) of extemal, visceral or skeletal findings did not reveal any substance-related fmdings in the fetuses of any treatment group.

Findings in dead fetuses
External examination of the dead fetuses did not reveal any substance-related effect.

Dose descriptor:

NOAEL

Effect level:

> 1 000 mg/kg bw/day

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Remarks:

Only slightly higher post-implantation loss as a secondary effect due to rat specific dental fluorosis in dams resulting from the high amount of a fluoride impurity were observed at the highest dose level

Abnormalities:

no effects observed

Developmental effects observed:

no

Conclusions:

Slightly lower body weight gains and a slight initial reduction in feed consumption resulting in slightly lower numbers of live foetuses at birth (not statistically significant) and a slightly higher post-implantation loss were observed at at 1000 mg/kg body weight/day. These effects were due to dental problems, resulting from higher fluoride uptake leading to a higher brittleness of the rat teeth. As the registered substance does not containf fluorine or fluoride as an impurity, these effects are of not relevance for the risk assessment of the test substance. Individual examination and statistical evaluation of external, visceral and skeletal effects did not reveal any substance related findings, including the high dose group. Hence the test substance was not teratogenic in the rat at either dose level.
Neither maternal nor embryo-foetal toxicity was observed after administration of at the daily dose of 250 mg/kg body weight. With regard to the present study the 'No Observed Effect Level' (NOEL) is 250 mg/kg bw/day for maternal toxicity and embryotoxicity and the NOAEL is considered to be 1000 mg/kg bw/day.

Executive summary:

The present study was conducted in order to determine the effects of the Structural Analogue 01 (SA01) on maternal state of health, embryonic and foetal development when administered oral by gavage once daily to mated female Sprague Dawley rats from day 6 - 19 of pregnancy.

Groups of 23 mated female Sprague Dawley rats received the test item as a solution in deionized water oral by gavage once daily at the dose levels of 62.5, 250 or 1000 mg/kg body weight from day 6 - 19 of pregnancy (day 0: day of sperm detection) and were sacrificed on day 20 of pregnancy. The dosing volume was 5 mL/kg, corresponding to concentrations of 0, 12.5, 50 and 200 g/L.

Animals were observed daily for mortality and clinical signs of toxicity. Body weight and food consumption were determined regularly throughout the study.

At necropsy the dams were examined for macroscopically visible changes. The uterus was opened and the number of live and dead foetuses and the number of conceptuses undergoing resorption were determined. Body weights, crown-rump lengths, sex ratios of the foetuses and placental weights were determined and external, visceral and skeletal examinations of the foetuses performed.

RESULTS

Neither deaths nor substance-related clinical signs of intoxication occurred throughout the study. The faeces of high dose dams was dark discoloured.

Body weights gains of all pregnant females were slightly decreased in the high dose group (1000 mg/kg bw/day) during the treatment period, attaining statistical significance (p<0.05) at the end of treatment only. Statistical evaluation showed an initial reduction (p<0.05) of feed consumption in this group (study days 3-6) with subsequent recovery thereafter. Effects on body weight and food consumption in the high dose groups were further investigated in the extended one-generation study and were unequivocally related to the dental problems due to the higher fluoride content of the test item. As the target substance does not contain fluoride or fluorine, this effect is not relevant for risk assessment.

Body weight gains and food consumption remained unaffected by the administration of the test substance in the other groups.

 

No substance-related adverse effects were observed at necropsy. The kidneys of all high dose group females, and of a few mid dose group females, were dark discoloured, indicating systemic bioavailability and metabolic burden of the test substance in the body.

There was a slight increase in the number of early or late conceptuses undergoing resorption (post-implantation loss), as well as a slight and not statistically significant decrease in the number of live foetuses at birth in the high dose dams, resulting from the lower body weights and food consumption due to dental problems relating to the higher fluoride intake in this dose-group. No such findings were observed for mid or low dose group females. Foetal crown-rump lengths, litter size, sex ratios, foetal body weight and placental weights remained unaffected by the administration of the test substance in any group. External, visceral and skeletal examinations of the foetuses did not reveal any substance related alterations in any group.

 

CONCLUSION

In conclusion, slightly lower body weight gains and a slight initial reduction in feed consumption were observed in pregnant female Sprague Dawley rats after administration of the test item at the daily dose of 1000 mg/kg body weight/day during days 6-19 of gestation. This was related to dental problems, as the higher fluoride uptake (0.3% fluoride was identified as an impurity of the test substance) leads to a higherbrittleness of the teeth for rats. Hence this effect is not of importance for the target substance. Resulting from the lower feed intake, high dose dams had slightly lower numbers of live foetuses at birth (not statistically significant) and a slightly higher post-implantation loss when compared to the control. In the presence of a normal intrauterine development of the remaining conceptuses, these findings were still on the lower/upper range of biological variation for this rat strain and hence, considered to be of equivocal toxicological significance. Moreover, individual examination and statistical evaluation of external, visceral and skeletal effects did not reveal any substance related findings, including the high dose group.

Neither maternal nor embryo-foetal toxicity was observed after administration of at the daily dose of 250 mg/kg body weight. The test substance was not teratogenic in the rat. With regard to the present study the 'No Observed Effect Level' (NOEL) is 250 mg/kg bw/day for maternal toxicity and embryotoxicity and the NOAEL is considered to be 1000 mg/kg bw/day with regard to human risk assessment.

There was no evidence of developmental toxicity in rats for the test substance, according to the classification criteria of Commission Directive 2001/59/EC.

Reference 3

Endpoint:

developmental toxicity

Type of information:

read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

supporting study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Justification for type of information:

REPORTING FORMAT FOR THE ANALOGUE APPROACH
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
see attachment section 13

2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
see attachment section 13

3. ANALOGUE APPROACH JUSTIFICATION
see attachment section 13

Reason / purpose for cross-reference:

read-across source

Clinical signs:

no effects observed

Mortality:

no mortality observed

Body weight and weight changes:

no effects observed

Food consumption and compound intake (if feeding study):

no effects observed

Number of abortions:

no effects observed

Pre- and post-implantation loss:

no effects observed

Total litter losses by resorption:

no effects observed

Early or late resorptions:

no effects observed

Dead fetuses:

no effects observed

Changes in number of pregnant:

no effects observed

Details on maternal toxic effects:

Maternal toxic effects:no effects

Details on maternal toxic effects:
black discoloration of feces and blue discoloration of urine due to excretion of dye

Dose descriptor:

NOAEL

Effect level:

> 1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Dose descriptor:

NOEL

Effect level:

>= 1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Abnormalities:

no effects observed

Fetal body weight changes:

no effects observed

Reduction in number of live offspring:

no effects observed

Changes in sex ratio:

no effects observed

Changes in litter size and weights:

no effects observed

Changes in postnatal survival:

no effects observed

External malformations:

no effects observed

Skeletal malformations:

no effects observed

Visceral malformations:

no effects observed

Details on embryotoxic / teratogenic effects:

Embryotoxic / teratogenic effects:no effects

Details on embryotoxic / teratogenic effects:
only minor anomalies or variation within the historical range of spontaneous findings were observed

Dose descriptor:

NOAEL

Effect level:

> 1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Abnormalities:

no effects observed

Developmental effects observed:

no

Conclusions:

No adverse effects were observed after daily administration of 1000 mg/kg/day in dams or their fetuses.

Executive summary:

In this limit test, the test substance, dissolved in distilled water, was administered orally by stomach tube in a single daily dose of 1000 mg/kg body weight to a group of 20 pregnant female Wistar rats from the 7th - 16th day of pregnancy. A simultaneous control group of the same size received the vehicle without test compound. On the 21st day of pregnancy, the dams were killed and delivered by caesarean section. The foetuses delivered by caesarean section were then examined morphologically for developmental disorders.

The study showed that the repeated oral administration of the test substance, at a dose of 1000 mg/kg body weight in the sensitive phase of organogenesis for the conceptuses, did not lead to any impairment of the general physical condition of the dams or impaired intrauterine development of conceptuses.

The morphological examination of the foetuses with regard to stage of development, outwardly detectable anomalies as well as anomalies of the internal organs and the skeleton showed no indication of an embryotoxic or teratogenic effect of the compound. The findings observed are to be regarded as spontaneous in origin.

On the basis of the results of this limit test, the “no observed adverse effect level” in rats following oral administration lies at 1000 mg/kg body weight with regard to maternal and embryofoetal toxicity and teratogenicity.

By read across to the substance "Reactive Black 5", Reactive Orange DYPR 1410 is also deemed to have no teratogenicity associated with it.

Reference 4

Endpoint:

developmental toxicity

Type of information:

experimental study

Adequacy of study:

supporting study

Study period:

14 September to 25 November 1993

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 414 (Prenatal Developmental Toxicity Study)

GLP compliance:

yes

Limit test:

yes

Species:

rat

Strain:

Wistar

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Hoechst AG
- Age at study initiation: 65 to 75 days
- Weight at study initiation: 193.1 +/- 14.2
- Fasting period before study: NA
- Housing: single
- Diet: Altromin 1310 ad libitum
- Water: tap water ad libitum
- Acclimation period: 7 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 22°C
- Humidity (%): 48 to 61%
- Air changes (per hr): 16 to 20
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 14. Sep To: 25. Nov 1993

Route of administration:

oral: gavage

Vehicle:

water

Details on exposure:

PREPARATION OF DOSING SOLUTIONS:
- Frequency of preparation: daily
- Administration: within 3 hours after preparation

VEHICLE
- Concentration in vehicle: 200 mg/kg nominal
- Amount of vehicle (if gavage): 5 ml/kg

Analytical verification of doses or concentrations:

not specified

Details on analytical verification of doses or concentrations:

-

Details on mating procedure:

- Impregnation procedure: cohoused
- M/F ratio per cage: 1:1
- Length of cohabitation: over night (3:30 pm to 7:30 am next day)
- Verification of same strain and source of both sexes: yes - own breeding facility
- Proof of pregnancy: sperm in vaginal smear, referred to as day 1 of pregnancy

Duration of treatment / exposure:

7. - 16. day of pregnancy

Frequency of treatment:

daily

Duration of test:

cesarean section on Day 21 of pregnancy

No. of animals per sex per dose:

20 to 24 mated females

Control animals:

yes, concurrent vehicle

Details on study design:

- Dose selection rationale: test item was tolerated in the acute and subacute studies without adverse effects

Maternal examinations:

CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily

BODY WEIGHT: Yes
- Time schedule for examinations: weekly

FOOD CONSUMPTION AND COMPOUND INTAKE : Yes
- Time schedule for examinations: weekly
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/100 g body weight/day: Yes

POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21
- Organs examined: all organs examined macroscopically
uterus - live and dead fetuses, resorption sites, placentas
ovaries - corpora lutea

OTHER:
- diameter of conceptuses undergoing resorption
- placenta weights
- presence of iron in uterus walls with ammonium sulphide to detect invisible implantation sites

Ovaries and uterine content:

The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No
- Placenta weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes

Fetal examinations:

- External examinations: Yes: all per litter
- Body weight: Yes: all per litter
- Crown-rump length: Yes: all per litter
- Soft tissue examinations: Yes: half per litter
- Skeletal examinations: Yes: half per litter
- Head examinations: No data

Statistics:

comparison to actual control group and historical controls
MANOVA: body weight development, fetal weight, placental weight
PURI&SEN rank order test: food intake
Mantel-Haenszel's chi-squared test: live fetuses, intrauterine fetal death, number of implants, number of corpora lutea
multivariate analysis of variance: litter means of fetal weights, crown-rump length, placental weights
Fisher test: autopsy findings, body cross-sections, skelettal examination

Dams which had no live fetuses were excluded from the calculation of mean values and statistical evaluation

Indices:

No data

Historical control data:

Yes

Clinical signs:

no effects observed

Mortality:

no mortality observed

Body weight and weight changes:

no effects observed

Food consumption and compound intake (if feeding study):

no effects observed

Number of abortions:

no effects observed

Pre- and post-implantation loss:

no effects observed

Total litter losses by resorption:

no effects observed

Early or late resorptions:

no effects observed

Dead fetuses:

no effects observed

Changes in pregnancy duration:

no effects observed

Changes in number of pregnant:

no effects observed

Details on maternal toxic effects:

Maternal toxic effects:no effects

Details on maternal toxic effects:
black discoloration of feces and blue discoloration of urine due to excretion of dye

Dose descriptor:

NOAEL

Effect level:

> 1 000 mg/kg bw/day (nominal)

Remarks on result:

not determinable due to absence of adverse toxic effects

Dose descriptor:

NOEL

Effect level:

>= 1 000 mg/kg bw/day (nominal)

Remarks on result:

not determinable due to absence of adverse toxic effects

Abnormalities:

no effects observed

Fetal body weight changes:

no effects observed

Reduction in number of live offspring:

no effects observed

Changes in sex ratio:

no effects observed

Changes in litter size and weights:

no effects observed

Changes in postnatal survival:

no effects observed

External malformations:

no effects observed

Skeletal malformations:

no effects observed

Visceral malformations:

no effects observed

Details on embryotoxic / teratogenic effects:

Embryotoxic / teratogenic effects:no effects

Details on embryotoxic / teratogenic effects:
only minor anomalies or variation within the historical range of spontaneous findings were observed

Dose descriptor:

NOAEL

Effect level:

> 1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Dose descriptor:

NOEL

Effect level:

>= 1 000 mg/kg bw/day (nominal)

Based on:

test mat.

Remarks on result:

not determinable due to absence of adverse toxic effects

Abnormalities:

no effects observed

Developmental effects observed:

no

Conclusions:

No adverse effects were observed after daily administration of 1000 mg/kg/day in dams or their fetuses.
Maternal NOAEL: > 1000 mg/kg/day
Fetal NOAEL: > 1000 mg/kg/day

Executive summary:

In this limit test, the test substance, dissolved in distilled water, was administered orally by stomach tube in a single daily dose of 1000 mg/kg body weight to a group of 20 pregnant female Wistar rats from the 7th - 16th day of pregnancy. A simultaneous control group of the same size received the vehicle without test compound. On the 21st day of pregnancy, the dams were killed and delivered by caesarean section. The foetuses delivered by caesarean section were then examined morphologically for developmental disorders.

The study showed that the repeated oral administration of the test substance, at a dose of 1000 mg/kg body weight in the sensitive phase of organogenesis for the conceptuses, did not lead to any impairment of the general physical condition of the dams or impaired intrauterine development of conceptuses.

The morphological examination of the foetuses with regard to stage of development, outwardly detectable anomalies as well as anomalies of the internal organs and the skeleton showed no indication of an embryotoxic or teratogenic effect of the compound. The findings observed are to be regarded as spontaneous in origin.

On the basis of the results of this limit test, the “no observed adverse effect level” in rats following oral administration lies at 1000 mg/kg body weight with regard to maternal and embryofoetal toxicity and teratogenicity.

Effect on developmental toxicity: via oral route

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

NOAEL

1 000 mg/kg bw/day

Study duration:

subacute

Species:

rat

Effect on developmental toxicity: via inhalation route

Endpoint conclusion:

no study available

Effect on developmental toxicity: via dermal route

Endpoint conclusion:

no study available

Additional information

It was considered appropriate to apply read-across for this endpoint to studies on two structural analogues, both of whom contain similar functional groups to the substance to be registered. It is anticipated that metabolism of the two read across structures will result in the formation of common metabolites of the substance to be registered, hence this approach is considered suitable in order to address the overall toxicity of Reaktiv-Orange DYPR 1410.

 

A study was conducted in order to determine the effects of the Structural Analogue 01 on maternal state of health, embryonic and foetal development when administered oral by gavage once daily to mated female Sprague Dawley rats from day 6 - 19 of pregnancy.

Groups of 23 mated female Sprague Dawley rats received the test item as a solution in deionized water oral by gavage once daily at the dose levels of 62.5, 250 or 1000 mg/kg body weight from day 6 - 19 of pregnancy (day 0: day of sperm detection) and were sacrificed on day 20 of pregnancy.

Neither deaths nor substance-related clinical signs of intoxication occurred throughout the study. The faeces of high dose dams was dark discoloured.

Body weights gains and food consumption of all pregnant females were slightly decreased in the high dose group (1000 mg/kg bw/day) during the treatment period or on study days 3-6, respectively. Effects on body weight and food consumption in the high dose groups were further investigated in the extended one-generation study and were unequivocally related to the dental problems due to the higher fluoride content of the test item. As Reactive Orange DYPR 1410 does not contain fluoride or fluorine, this effect is not relevant for risk assessment.

Body weight gains and food consumption remained unaffected by the administration of the test substance in the other groups.

No substance-related adverse effects were observed at necropsy. The kidneys of all high dose group females, and of a few mid dose group females, were dark discoloured, indicating systemic bioavailability and metabolic burden of the test substance in the body.

There was a slight increase in the number of early or late conceptuses undergoing resorption (post-implantation loss), as well as a slight and not statistically significant decrease in the number of live foetuses at birth in the high dose dams, resulting from the lower body weights and food consumption due to dental problems relating to the higher fluoride intake in this dose-group. No such findings were observed for mid or low dose group females. Foetal crown-rump lengths, litter size, sex ratios, foetal body weight and placental weights remained unaffected by the administration of the test substance in any group. External, visceral and skeletal examinations of the foetuses did not reveal any substance related alterations in any group.

In conclusion, slightly lower body weight gains and a slight initial reduction in feed consumption were observed in pregnant female Sprague Dawley rats after administration of the test item at the daily dose of 1000 mg/kg body weight/day during days 6-19 of gestation. This was related to dental problems, as the higher fluoride uptake (0.3% fluoride was identified as an impurity of the test substance) leads to a higher brittleness of the rat teeth. Hence this effect is not of importance for Reactive Orange DYPR 1410. Resulting from the lower feed intake, high dose dams had slightly lower numbers of live foetuses at birth (not statistically significant) and a slightly higher post-implantation loss when compared to the control. In the presence of a normal intrauterine development of the remaining conceptuses, these findings were still on the lower/upper range of biological variation for this rat strain and hence, considered to be of equivocal toxicological significance. Moreover, individual examination and statistical evaluation of external, visceral and skeletal effects did not reveal any substance related findings, including the high dose group.

As the effects observed were rats specific effects due to the different physiology and anatomy of rat teeth compared to human teeth, the 'No Observed Adverse Effect Level' (NOAEL) is considered to be 1000 mg/kg bw/day.

Due to the fact that no fluoride is contained in Reactive Orange DYPR 1410 no adverse effects on reproductive performance of parental animals or their offspring is expected for Reactive Orange DYPR 1410 up to a limit dose of 1000 mg/kg body weight.

 

In a second teratogencity study Reactive Black 5, also called Remazol Black B SD, dissolved in distilled water, was administered orally by stomach tube. The study showed that the repeated oral administration of C.I. Reactive Black 5, at a dose of 1000 mg/kg body weight in the sensitive phase of organogenesis for the conceptuses, did not lead to any impairment of the general physical condition of the dams or impaired intrauterine development of conceptuses. The morphological examination of the foetuses with regard to stage of development, outwardly detectable anomalies as well as anomalies of the internal organs and the skeleton showed no indication of an embryotoxic or teratogenic effect of the compound. The findings observed are to be regarded as spontaneous in origin. On the basis of the results of this limit test, the “no observed adverse effect level” for C.I. Reactive Black 5 in rats following oral administration lies at 1000 mg/kg body weight with regard to maternal and embryo foetal toxicity and teratogenicity. No teratogenic effect was observed.

Justification for classification or non-classification

The above studies have all been ranked reliability 1 according to the Klimisch et al system. This ranking was deemed appropriate because the studies were conducted to GLP an in compliance with agreed protocols. Sufficient dose ranges and numbers are detailed; hence it is appropriate for use based on reliability and animal welfare grounds. As the effects are considered adaptive rather than toxicological, no classification is proposed.

The above results triggered no classification under the Dangerous Substance Directive (67/548/EEC) and the CLP Regulation (EC No 1272/2008). No classification for prolonged effects is therefore required.